Paul Tudor Jones II's position in Abbvie is currently worth $1.45M. That's 0.01% of their equity portfolio (980th largest holding). The first Abbvie trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 28 more times and sold shares on 26 occasions. The stake costed the investor $1.26M, netting the investor a gain of 15% so far.
Since 1928, there have been 25 bear markets, or declines in the S&P 500 of 20% or more, according to Yardeni Research. Market corrections have been far more ...